Back to top
more

Phibro Animal Health (PAHC)

(Real Time Quote from BATS)

$25.34 USD

25.34
200,063

+1.49 (6.25%)

Updated Nov 11, 2024 01:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Omnicell-Geisinger Deal Improves Patient Care via Automation

by Zacks Equity Research

Omnicell's (OMCL) XT series Automated Dispensing Systems partners with Geisinger to streamline nursing workflow and improve patient care.

PRGO or PAHC: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Phibro (PAHC) Q2 Earnings Top Estimates, Revenues Fall Y/Y

by Zacks Equity Research

Phibro (PAHC) witnessed revenue decline in two of its core segments and contraction in operating margin in Q2.

PRGO vs. PAHC: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Here's Why You Should Hold on to Phibro (PAHC) Stock Now

by Zacks Equity Research

Investors can retain Phibro (PAHC) stock for now, thanks to its solid prospects.

Why Is Phibro (PAHC) Up 8.5% Since Last Earnings Report?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Phibro's (PAHC) Q1 Earnings & Revenues Fall Y/Y, Margins Down

by Zacks Equity Research

Phibro (PAHC) exhibits a dismal first-quarter performance on a decline in revenues at core business segments.

Phibro (PAHC) Suffers Dismal Segmental Sales, Margin Woes

by Zacks Equity Research

Per Phibro Animal (PAHC), weak demand in Animal Health business due to swine flu outbreak in China along with an unfavorable product mix in Mineral Nutrition is dampening.

Why Is Phibro (PAHC) Up 0.4% Since Last Earnings Report?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for September 3rd

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Phibro's (PAHC) Q4 Earnings Miss Estimates, Revenues Fall Y/Y

by Zacks Equity Research

Phibro's (PAHC) revenue decline across two core segments and contraction in operating margin are concerning.

Phibro Animal Sees Crucial Progress in ASF Vaccine Development

by Zacks Equity Research

The identification of a group of peptides and proteins is a remarkable step toward Phibro's (PAHC) development of a solution for ASF.

Phibro (PAHC) Up 3.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Phibro's (PAHC) Q3 Earnings Miss Estimates, Margins Fall

by Zacks Equity Research

Phibro Animal Health (PAHC) sees year-over-year revenue decline in two core segments ??? Animal Health and Mineral Nutrition.

Phibro Animal Solid on Global Prospects, Currency Woes Ail

by Zacks Equity Research

Phibro Animal (PAHC) has been gaining from strong volume growth in foreign markets. However, adverse currency movements remain a concern.

Phibro (PAHC) Down 6.2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Phirbo (PAHC) Q2 Earnings Lag Estimates, Operating Margin Up

by Zacks Equity Research

Phirbo (PAHC) witnesses significant growth in core segment revenues in Q2.

Moving Average Crossover Alert: Phibro Animal Health Corporation

by Zacks Equity Research

Phibro Animal Health Corporation could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Phibro (PAHC) Down 14.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Moving Average Crossover Alert: Phibro Animal Health (PAHC)

by Zacks Equity Research

Phibro Animal Health (PAHC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

Phibro Animal (PAHC) Q1 Earnings Lag Estimates, Sales Up Y/Y

by Zacks Equity Research

Within Animal Health business of Phirbo Animal (PAHC), reduced selling prices across certain countries partially offset its international volume growth.

Why Is Phibro (PAHC) Down 13.3% Since Last Earnings Report?

by Zacks Equity Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Here's Why You Should Invest in Phibro (PAHC) Right Now

    by Zacks Equity Research

    Phibro (PAHC) sees improvement across all segments. The Animal Health business has been a key contributor.

      Phibro Animal (PAHC) Q4 Earnings Beat, Sales Improve Y/Y

      by Zacks Equity Research

      Phibro (PAHC) witnesses year-over-year improvement across all segments in Q4.

        Why Is Phibro Animal (PAHC) Up 10.7% Since Its Last Earnings Report?

        by Zacks Equity Research

        Phibro Animal (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.